Clear, Essential User Information
GMLP Principle 9. Tell users what they need to know: intended use, benefits, risks, subgroup performance, methodology, inputs, limitations, model output basis.
Overview
User information is the bridge between what your device does in study conditions and what users can do with it in practice. Vague or omitted user information leads to misapplication, complaints, and regulatory exposure.
We design labeling, IFUs, and in-product transparency that respect the user's intelligence and protect against foreseeable misuse.
Our Process
-
1
Information inventory
What does a user need to know to use this safely and effectively?
-
2
Audience tailoring
Per user role: clinician, technician, administrator.
-
3
Drafting
Labeling, IFU, in-product disclosures.
-
4
Human factors review
Comprehensibility tested with target users.
-
5
Regulatory alignment
FDA labeling guidance, EU MDR Annex I information.
Frequently Asked Questions
What about subgroup performance disclosure?
Increasingly expected. We design appropriate disclosure formats.
In-product disclosures vs. IFU?
Both, designed to reach the user in context.
Translations?
Yes, for multi-country markets with appropriate validation.
Standards alignment?
FDA labeling, IEC 62366, EU MDR Annex I.
Tell users what they need to know.
Send us your current labeling and user docs. We will return a refresh plan within three weeks.
Start a Conversation